IE 11 is not supported. For an optimal experience visit our site on another browser.

U.S. AstraZeneca trial finds vaccine is 79 percent effective against Covid


A Phase 3 trial of the AstraZeneca vaccine conducted in the U.S. found that the Covid-19 vaccine was 79 percent effective against symptomatic illness and 100 percent effective in stopping severe and fatal cases of the disease.